Skip to Content

POTTERS ANTISEPTIC OINTMENT

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

SUMMARY OF PRODUCT CHARACTERISTICS
1

NAME OF THE MEDICINAL PRODUCT
POTTER’S ANTISEPTIC OINTMENT

2

3

QUALITATIVE AND QUANTITATIVE COMPOSITION

Ingredients: Menthol BP 0.015 % W/W; Methyl Salicylate BP 3.0% W/W;
Liquefied Phenol BP 1.0 w/w; Starch BP 8.0 % W/W; Zinc Oxide BP 8.0 %
W
/W; Woolfat BP 3.25 % W/W; Hard Paraffin BP 5.0 % W/W

PHARMACEUTICAL FORM
OINTMENT

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
Minor wounds, abrasions and cuts.

4.2

Posology and method of administration
Apply directly to the affected parts.

4.3

Contraindications
None.

4.4

Special warnings and precautions for use
Keep medicines away from children.

4.5

Interaction with other medicinal products and other forms of interaction
None.

4.6

Pregnancy and lactation
May be used.

4.7

Effects on ability to drive and use machines
None.

4.8

Undesirable effects
None.

4.9

Overdose
No cases known.

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Menthol has analgesic and antipruritic actions. Methyl Salicylate relieves pain.
Liquefied Phenol has bacteriostatic and local anaesthetic actions. Starch and
Zinc Oxide have protective actions and Zinc Oxide is also soothing and a mild
astringent.

5.2

Pharmacokinetic properties
No information available.

5.3

Preclinical safety data
No information available.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
Erythrosine aluminium lake and Yellow Soft Paraffin.

6.2

Incompatibilities
None known.

6.3

Shelf life
Three years.

6.4

Special precautions for storage
None.

6.5

Nature and contents of container
Polythene pot with push-on closure or glass jar with hard plastic screwoap:
500 g. Polyethylene jar with hard plastic screwcap: 28 g. Glass jar with hard
plastic screwcap 28 g.

6.6

Special precautions for disposal
Not applicable.

7

MARKETING AUTHORISATION HOLDER
Rutland Biodynamics Ltd
Town Park Farm
Brooke
Rutland
LE15 8DG

8

MARKETING AUTHORISATION NUMBER(S)
PL 28255/0015

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
23rd February 1987

10

DATE OF REVISION OF THE TEXT
January 1996

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide